For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues.
Scope of the Report:
This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of enzymatic debridement is in the decreasing trend, from 81.3 USD/ Unit in 2012 to 76.4 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of enzymatic debridement includes collagenase product, papain product and other product, and the proportion of collagenase product in 2016 is about 75%.
Enzymatic debridement is widely used in hospitals, clinics and other field. The most proportion of enzymatic debridement is hospitals, and the consumption proportion is about 49% in 2016.
North America region is the largest supplier of enzymatic debridement, with a production market share nearly 44% in 2016. Europe is the second largest supplier of Enzymatic Debridement, enjoying production market share nearly 29% in 2016.
North America is the largest consumption place, with a consumption market share nearly 61% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 15%.
Market competition is intense. Smith & Nephew is the leaders of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
The worldwide market for Enzymatic Debridement is expected to grow at a CAGR of roughly 7.2% over the next five years, will reach 280 million US$ in 2023, from 190 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Smith & Nephew
- Stratus Pharma
- WeiBang Biopharm
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Collagenase Product
- Papain Product
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Enzymatic Debridement market.
Chapter 1, to describe Enzymatic Debridement Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Enzymatic Debridement, with sales, revenue, and price of Enzymatic Debridement, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Enzymatic Debridement, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Enzymatic Debridement market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Enzymatic Debridement sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source